Total Payments
$1,505
2024 Payments
$409.38
Companies
17
Transactions
35
Medicare Patients
1,377
Medicare Billing
$156,560
Payment Breakdown by Category
Education$809.01 (53.7%)
Food & Beverage$696.20 (46.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $809.01 | 10 | 53.7% |
| Food and Beverage | $696.20 | 25 | 46.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $425.69 | 5 | $0 (2024) |
| Incyte Corporation | $283.89 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $140.79 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $125.00 | 1 | $0 (2021) |
| Seagen Inc. | $99.99 | 1 | $0 (2023) |
| SOBI, INC | $99.18 | 5 | $0 (2024) |
| GENZYME CORPORATION | $70.55 | 3 | $0 (2024) |
| CTI BioPharma Corp. | $66.20 | 4 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $38.41 | 1 | $0 (2024) |
| Celgene Corporation | $29.15 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $409.38 | 16 | SOBI, INC ($99.18) |
| 2023 | $196.64 | 6 | Seagen Inc. ($99.99) |
| 2022 | $99.95 | 1 | Janssen Biotech, Inc. ($99.95) |
| 2021 | $224.00 | 2 | Daiichi Sankyo Inc. ($125.00) |
| 2020 | $99.95 | 1 | Janssen Biotech, Inc. ($99.95) |
| 2019 | $150.24 | 4 | Janssen Biotech, Inc. ($99.00) |
| 2018 | $212.03 | 3 | Merck Sharp & Dohme Corporation ($112.08) |
| 2017 | $113.02 | 2 | Incyte Corporation ($99.95) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Oncology | ||||||
| 11/05/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Hematology | ||||||
| 10/16/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $83.99 | General |
| 10/16/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 09/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 06/02/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $38.41 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Hematology | ||||||
| 04/24/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/19/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/27/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Hematology | ||||||
| 01/09/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Hematology | ||||||
| 12/05/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: Hematology | ||||||
| 11/28/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Hematology | ||||||
| 10/17/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Hematology | ||||||
| 08/15/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Hematology | ||||||
| 03/21/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 04/05/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 08/04/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 08/03/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 294 | 468 | $216,920 | $32,231 |
| 2022 | 8 | 331 | 510 | $244,987 | $35,694 |
| 2021 | 9 | 381 | 680 | $332,605 | $54,277 |
| 2020 | 10 | 371 | 540 | $203,983 | $34,357 |
Total Patients
1,377
Total Services
2,198
Medicare Billing
$156,560
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 139 | $90,350 | $15,030 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 51 | $26,240 | $3,833 | 14.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 27 | $17,225 | $2,984 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 38 | $20,330 | $2,793 | 13.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 27 | 30 | $26,700 | $2,293 | 8.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $14,920 | $2,208 | 14.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $13,140 | $1,771 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 88 | 157 | $8,015 | $1,319 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 102 | $66,300 | $11,149 | 16.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 63 | 64 | $52,020 | $5,970 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 71 | $31,950 | $5,505 | 17.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 51 | $29,325 | $4,759 | 16.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $20,805 | $3,496 | 16.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 44 | $23,540 | $2,726 | 11.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $13,645 | $1,660 | 12.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 79 | 145 | $7,402 | $429.45 | 5.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 102 | $63,780 | $11,798 | 18.5% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 11 | 60 | $47,400 | $9,600 | 20.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 36 | 92 | $50,500 | $8,919 | 17.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 96 | $43,200 | $7,026 | 16.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 68 | 68 | $53,705 | $6,649 | 12.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 60 | $31,675 | $4,055 | 12.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $18,800 | $3,091 | 16.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $15,020 | $2,638 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 89 | 167 | $8,525 | $501.00 | 5.9% |
About Dr. Daniel Friedman, MD
Dr. Daniel Friedman, MD is a Hematology & Oncology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538180252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Friedman, MD has received a total of $1,505 in payments from pharmaceutical and medical device companies, with $409.38 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Education" ($809.01).
As a Medicare-enrolled provider, Friedman has provided services to 1,377 Medicare beneficiaries, totaling 2,198 services with total Medicare billing of $156,560. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bronx, NY
- Active Since 07/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1538180252
Products in Payments
- IMBRUVICA (Drug) $198.00
- Enhertu (Drug) $125.00
- DARZALEX (Biological) $99.95
- ERLEADA (Drug) $99.95
- VONJO (Drug) $99.18
- Vonjo (Drug) $66.20
- CABLIVI (Biological) $53.79
- ZEPZELCA (Drug) $38.41
- KEYTRUDA (Biological) $37.69
- REBLOZYL (Biological) $29.15
- TALVEY (Biological) $27.79
- QULIPTA (Drug) $26.76
- TAGRISSO (Drug) $20.11
- SARCLISA (Biological) $16.76
- SCEMBLIX (Drug) $15.18
- GILOTRIF (Drug) $14.16
- ZYTIGA (Drug) $13.07
- IBRANCE (Drug) $11.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bronx
Dr. Mark Chaitowitz, Md, MD
Hematology & Oncology — Payments: $13,776
Hematology & Oncology $13,776
Stuart Packer, Md, MD
Hematology & Oncology — Payments: $13,717
Hematology & Oncology $13,717
Mr. Howard Bruckner, M.d, M.D
Hematology & Oncology — Payments: $12,939
Hematology & Oncology $12,939
Dr. Avi Retter, Md, MD
Hematology & Oncology — Payments: $11,928
Hematology & Oncology $11,928
Dr. Ilmana Fulger, Md, MD
Hematology & Oncology — Payments: $9,395
Hematology & Oncology $9,395
Dr. Ivette Vigoda, Md, MD
Hematology & Oncology — Payments: $8,453
Hematology & Oncology $8,453